lovastatin has been researched along with Bone Diseases, Developmental in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elefteriou, F; Nyman, JS; Ono, K; Stevenson, DA; Wang, W; Yang, X | 1 |
Beccari, T; Bennati, AM; Caruso, D; Castelli, M; Della Fazia, MA; Roberti, R; Servillo, G | 1 |
2 other study(ies) available for lovastatin and Bone Diseases, Developmental
Article | Year |
---|---|
Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.
Topics: Animals; Bone and Bones; Bone Diseases, Developmental; Bone Remodeling; Chondrocytes; Collagen Type II; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Intervertebral Disc; Lovastatin; Mice; Mice, Knockout; Neurofibromatosis 1; Neurofibromin 1; Osteoblasts; Osteocytes; Osteogenesis; Phenotype; Porosity; Promoter Regions, Genetic; ras Proteins; Recombination, Genetic; Stem Cells | 2011 |
Sterol dependent regulation of human TM7SF2 gene expression: role of the encoded 3beta-hydroxysterol Delta14-reductase in human cholesterol biosynthesis.
Topics: Bone Diseases, Developmental; Cholesterol; Gene Expression Regulation; Humans; Hydroxycholesterols; Lamin B Receptor; Lovastatin; Membrane Proteins; Mutation; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Receptors, Cytoplasmic and Nuclear; Sterol Regulatory Element Binding Protein 2 | 2006 |